<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M623</article-id>
      <article-id pub-id-type="publisher-id">molbank-2009-M623</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>5-Methyl-4-oxo-4,6-dihydro-3<italic>H</italic>-pyridazino[4,5-<italic>b</italic>]carbazole-1-carbaldehyde</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Emich</surname>
            <given-names>Miriam</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <xref rid="c1-molbank-2009-M623" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2009-M623">Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2009-M623"><label>*</label> Author to whom correspondence should be addressed; E-mail: <email>norbert.haider@univie.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2009</year>
      </pub-date>
      <volume>2009</volume>
      <issue>4</issue>
      <elocation-id>M623</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>10</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>10</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound was prepared in good yield by oxidation of 1-(hydroxy-methyl)-5-methyl-3,6-dihydro-4<italic>H</italic>-pyridazino[4,5-<italic>b</italic>]carbazol-4-one with 2-iodoxybenzoic acid (IBX) in DMSO solution under very mild conditions.</p>
      </abstract>
      <kwd-group>
        <kwd>pyridazino[4,5-<italic>b</italic>]carbazole</kwd>
        <kwd>oxidation</kwd>
        <kwd>2-iodoxybenzoic acid</kwd>
        <kwd>IBX</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>In the course of our department&#x2019;s ongoing research in the field of antitumor agents [<xref ref-type="bibr" rid="B1-molbank-2009-M623">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2009-M623">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2009-M623">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2009-M623">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2009-M623">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2009-M623">6</xref>], we previously reported the synthesis of a novel 3-aza analogue of the antitumor alkaloid, <italic>olivacine</italic> (1,5-dimethyl-6<italic>H</italic>-pyrido[4,3-<italic>b</italic>]carbazole) [<xref ref-type="bibr" rid="B7-molbank-2009-M623">7</xref>]. One of the compounds prepared in this context was the carbazole-fused hydroxymethylpyridazinone <bold>1</bold>, which we had envisaged as a useful intermediate for the synthesis of new functionalized pyridazino[4,5-<italic>b</italic>]carbazoles with structural similarity to <italic>olivacine</italic> and related pyridocarbazoles. However, initial attempts to transform the hydroxymethyl group of <bold>1</bold> into an aldehyde or carboxylic acid functionality had given poor results, mainly because of the very low solubility of compound <bold>1</bold> in common solvents except dipolar aprotic solvents like DMSO. We now wish to report the convenient oxidation of <bold>1</bold> into the corresponding aldehyde <bold>2</bold> in DMSO solution, using a hypervalent iodine oxidizing agent.</p>
      <p>2-Iodoxybenzoic acid (IBX) was found to be the reagent of choice for this transformation, as it is typically used in DMSO solution at room temperature and permits the oxidation of alcohols into carbonyl compounds under very mild conditions [<xref ref-type="bibr" rid="B8-molbank-2009-M623">8</xref>]. As the only byproduct, one equivalent of 2-iodosobenzoic acid (IBA) is formed, which either is removed by filtration or is lost during extractive work-up. In the case of our compound, the work-up procedure had to be slightly modified: after completion of the oxidation reaction, dilution of the DMSO solution with water led to precipitation of both the product <bold>2</bold> and IBA (containing also some unreacted IBX). The higher specific weight and larger particle size of the latter, however, permitted the separation from the product (<bold>2</bold>) simply by decantation of the supernatant fine slurry containing the aldehyde. The structure of the title compound thus obtained in 71% yield clearly follows from its spectral data. The IR spectrum shows a carbonyl absorption of the formyl group at 1694 cm<sup>-1</sup> in addition to the pyridazinone carbonyl band at 1642 cm<sup>&#x2011;1</sup>. In the <sup>1</sup>H NMR spectrum, the aldehyde proton appears as singulet at 9.83 ppm, the <sup>13</sup>C NMR spectrum shows the aldehyde carbon signal at 191.9 ppm. The title compound will be used as building block for further structural modifications at the pyridazine subunit of the tetracyclic system.</p>
	  <disp-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M623-i001.tif"/></disp-formula>
    <sec sec-type="methods">
      <title>Experimental</title>
      <p>The melting point was determined on a Kofler hot-stage microscope (Reichert) and is uncorrected. The IR spectrum was recorded on a Perkin-Elmer Spectrum 1000 instrument, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Varian UnityPlus 300 spectrometer. The low-resolution mass spectrum was obtained on a Shimadzu QP5050A DI 50 instrument, the HR-MS was recorded on a Finnigan MAT 8230 at the Institute of Organic Chemistry, University of Vienna. Microanalysis was performed at the Microanalytical Laboratory, Faculty of Chemistry, University of Vienna. IBX was freshly prepared from 2-iodobenzoic acid, following the reported procedure [<xref ref-type="bibr" rid="B9-molbank-2009-M623">9</xref>].</p>
      <sec id="sec5-molbank-2009-M623">
        <title>5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbaldehyde <italic>(<bold>2</bold>)</italic></title>
        <p>To a solution of 1-(hydroxymethyl)-5-methyl-3,6-dihydro-4<italic>H</italic>-pyridazino[4,5-<italic>b</italic>]carbazol-4-one (<bold>1</bold>) [<xref ref-type="bibr" rid="B7-molbank-2009-M623">7</xref>] (280 mg, 1 mmol) in DMSO (5 mL) was added a solution of 2-iodoxybenzoic acid (IBX) (420 mg, 1.5 mmol) in DMSO (5 mL), and the mixture was stirred in a closed vessel at room temperature for 24 h. Water (50 mL) was added and the fine greenish slurry was carefully decanted from the heavier yellowish precipitate of IBA/IBX. The slurry was filtered and the crude material thus obtained was washed with water and dried <italic>in vacuo</italic>. It was then purified by repeated washing with boiling methanol to give the aldehyde <bold>2</bold> as light-greenish crystals, m.p. &gt;350 &#xB0;C;  yield: 198 mg (71%).</p>
        <p>IR (KBr): 3330, 3166, 1694, 1642, 1500, 1263, 1239, 820 cm<sup>-1</sup>.</p>
        <p>MS (EI, 70 eV): m/z = 278 (20%), 277 (100, M<sup>+</sup>), 263 (29), 193 (64), 192 (37), 191. (24), 139 (15), 83 (18).</p>
        <p><sup>1</sup>H NMR (DMSO-<italic>d</italic><sub>6</sub>, 300 MHz): &#x3B4; = 3.10 (3H, s, 5-CH<sub>3</sub>), 7.25-7.31 (1H, m, 9-H), 7.53-7.62 (2H, m, 7-H, 8-H), 8.22 (1H, d, <italic>J</italic> = 7.8 Hz, 10-H), 9.52 (1H, s, 11-H; shows positive NOE on irradiation at 8.22 ppm), 9.83 (1H, s, aldehyde-H), 11.80 (1H, s, carbazole-NH; shows positive NOE on irradiation at 3.10 ppm), 12.99 (1H, s, pyridazinone-NH).</p>
        <p><sup>13</sup>C NMR (DMSO-<italic>d</italic><sub>6</sub>, 75 MHz): &#x3B4; = 15.4 (5-CH<sub>3</sub>), 111.6, 114.1, 119.8, 119.9, 120.8, 121.3, 121.8, 126.4, 128.2, 140.2, 141.0, 141.9, 143.9, 161.5 (4-C), 191.9 (aldehyde-C).</p>
        <p>Elemental Analysis: Calcd. for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub> &#x2022; 0.2 H<sub>2</sub>O: C, 68.42%; H, 4.09%; N, 14.96%. Found: C, 68.02%; H, 4.17%; N, 15.34%.</p>
        <p>HR-MS Calcd. for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>: 277.0851. Found: 277.0857</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2009-M623">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2009-M623-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M623-s001-mod.mol">
		<label>Supplementary File 1</label>
		</supplementary-material>
        <supplementary-material id="molbank-2009-M623-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2009-M623-s001.mol">
		<label>Supplementary File 2</label>
        </supplementary-material>
    </app>
	</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We are grateful to P. Unteregger for recording the high-resolution mass spectrum.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2009-M623">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Pyridazine-Fused Carbazoles: Synthesis, Reactivity, and Antitumor Activity</article-title>
          <source>J. Heterocyclic Chem.</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>511</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570390307</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2009-M623">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kabicher</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Plenk</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in-vitro</italic> antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>1900</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="doi">10.3390/12081900</pub-id>
          <pub-id pub-id-type="pmid">17960095</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2009-M623">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jbara</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Traar</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of tetra- and pentacyclic carbazole-fused imides as potential antitumor agents</article-title>
          <source>Arkivoc</source>
          <year>2009</year>
          <fpage>38</fpage>
          <lpage>47</lpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2009-M623">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Carbinol derivatives of azanaphthoquinone annelated pyrrols</article-title>
          <source>Monatsh. Chem.</source>
          <year>2009</year>
          <volume>140</volume>
          <fpage>309</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-008-0024-3</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2009-M623">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shanab</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wulz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aicher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;nther</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>6091</fpage>
          <lpage>6095</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.09.054</pub-id>
          <pub-id pub-id-type="pmid">17904839</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2009-M623">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dual function antitumor agents based on bioreduction and DNA alkylation</article-title>
          <source>Monatsh. Chem.</source>
          <year>2007</year>
          <volume>138</volume>
          <fpage>517</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-007-0604-7</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2009-M623">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sotelo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>1,5-Dimethyl-6<italic>H</italic>-pyridazino[4,5-b]carbazole, a 3-aza bioisoster of the antitumor alkaloid olivacine</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>1479</fpage>
          <lpage>1483</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.50.1479</pub-id>
          <pub-id pub-id-type="pmid">12419913</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2009-M623">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frigerio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Santagostino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sputore</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Palmisano</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Oxidation of Alcohols with o-Iodoxy-benzoic Acid (IBX) in DMSO: a New Insight into an Old Hypervalent Iodine Reagent</article-title>
          <source>J. Org. Chem.</source>
          <year>1995</year>
          <volume>60</volume>
          <fpage>7272</fpage>
          <lpage>7276</lpage>
          <pub-id pub-id-type="doi">10.1021/jo00127a036</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2009-M623">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frigerio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Santagostino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sputore</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>A User-Friendly Entry to 2-Iodoxybenzoic Acid (IBX)</article-title>
          <source>J. Org. Chem.</source>
          <year>1999</year>
          <volume>64</volume>
          <fpage>4537</fpage>
          <lpage>4538</lpage>
          <pub-id pub-id-type="doi">10.1021/jo9824596</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
